Latest News/ Blog

FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions’ SPOT-MAS 10 Multi-Cancer Screening Test  SINGAPORE, 28 May 2026 — Gene Solutions, a global biotechnology company advancing accessible genomic solutions for cancer detection

TAIPEI, May 22, 2026 — Gene Solutions, an innovative global biotechnology company advancing AI-powered multi-omics solutions for cancer detection and precision oncology, participated in the 30th Taiwan Joint Cancer Conference (TJCC 2026), marking

8 May marks World Thalassemia Day — a global moment to honor families living with thalassemia and raise awareness of inherited blood disorders. In 2026, the global campaign theme, “Hidden No More:

K-CONNECT SUMMIT 2026, co-hosted by Gene Solutions, the Vietnam Institute of Clinical Medicine and Pharmacy, and the Vietnam Medical Association, will convene oncologists, healthcare professionals, researchers, and international experts to advance scientific exchange in early

Deeper molecular insights, with faster turn-around time, for sooner decisions across the patient journey Singapore, 30 April 2026 — Gene Solutions has announced major upgrades to their K-TRACK and K-4CARE portfolios,

We’re pleased to share that, through our strategic collaboration with Genique Lifesciences, we are expanding access to advanced AI-enabled genomic testing in India — bringing genomic insights closer to clinical practice

April 20, 2026 — Gene Solutions announced the expansion of its SPOT‑MAS portfolio with two new solutions: SPOT-MAS CRC and SPOT-MAS Eva. These additions bring accessible blood-based colorectal cancer screening and

All-in-one approach integrates chromosomal analysis, single-gene disorder screening, and maternal carrier screening from a single blood draw. TAIPEI, April 14, 2026 /PRNewswire/ — At the prestigious Taiwan Association of Obstetrics and Gynecology (TAOG)

At the 1st Symposium on Genomics and Precision Oncology in Brazil (April 10–11), over 300 oncologists gathered to advance the future of cancer care and the Gene Solutions Brazil team

Multi-Cancer Early Detection (MCED) testing is an emerging approach that aims to identify signals associated with multiple cancers through a single blood sample. As awareness of MCED grows, some individuals

On 7 February 2026, the Gene Solutions Hong Kong team co-organized a public health talk in Hong Kong that brought together 40+ participants—including patients’ families and health‑conscious individuals—to address a

At the 2nd International Hereditary Cancers Congress (IHCC) held in Antalya, Türkiye (February 5–8, 2026), Gene Solutions – co-hosted with its Türkiye’s distribution partner – ATC – organized a dedicated